Literature DB >> 32818246

Deletions in BCP-ALL result in a TAD more FLT3.

David H Spencer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32818246      PMCID： PMC7441166          DOI： 10.1182/blood.2020006607

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

2.  13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.

Authors:  Minjun Yang; Setareh Safavi; Eleanor L Woodward; Nicolas Duployez; Linda Olsson-Arvidsson; Jonas Ungerbäck; Mikael Sigvardsson; Marketa Zaliova; Jan Zuna; Thoas Fioretos; Bertil Johansson; Karolin H Nord; Kajsa Paulsson
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

Review 3.  Mechanisms of B-cell lymphoma pathogenesis.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

4.  The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Henrik Lilljebjörn; Andrea Biloglav; Linda Olsson; Marianne Rissler; Anders Castor; Gisela Barbany; Linda Fogelstrand; Ann Nordgren; Helene Sjögren; Thoas Fioretos; Bertil Johansson
Journal:  Nat Genet       Date:  2015-05-11       Impact factor: 38.330

5.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.

Authors:  Joachim Weischenfeldt; Taronish Dubash; Alexandros P Drainas; Balca R Mardin; Yuanyuan Chen; Adrian M Stütz; Sebastian M Waszak; Graziella Bosco; Ann Rita Halvorsen; Benjamin Raeder; Theocharis Efthymiopoulos; Serap Erkek; Christine Siegl; Hermann Brenner; Odd Terje Brustugun; Sebastian M Dieter; Paul A Northcott; Iver Petersen; Stefan M Pfister; Martin Schneider; Steinar K Solberg; Erik Thunissen; Wilko Weichert; Thomas Zichner; Roman Thomas; Martin Peifer; Aslaug Helland; Claudia R Ball; Martin Jechlinger; Rocio Sotillo; Hanno Glimm; Jan O Korbel
Journal:  Nat Genet       Date:  2016-11-21       Impact factor: 38.330

6.  Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.

Authors:  Richard M Stone; Sumithra J Mandrekar; Ben L Sanford; Kristina Laumann; Susan Geyer; Clara D Bloomfield; Christian Thiede; Thomas W Prior; Konstanze Döhner; Guido Marcucci; Francesco Lo-Coco; Rebecca B Klisovic; Andrew Wei; Jorge Sierra; Miguel A Sanz; Joseph M Brandwein; Theo de Witte; Dietger Niederwieser; Frederick R Appelbaum; Bruno C Medeiros; Martin S Tallman; Jürgen Krauter; Richard F Schlenk; Arnold Ganser; Hubert Serve; Gerhard Ehninger; Sergio Amadori; Richard A Larson; Hartmut Döhner
Journal:  N Engl J Med       Date:  2017-06-23       Impact factor: 91.245

7.  Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma.

Authors:  Wen Fong Ooi; Amrita M Nargund; Kevin Junliang Lim; Shenli Zhang; Manjie Xing; Amit Mandoli; Jing Quan Lim; Shamaine Wei Ting Ho; Yu Guo; Xiaosai Yao; Suling Joyce Lin; Tannistha Nandi; Chang Xu; Xuewen Ong; Minghui Lee; Angie Lay-Keng Tan; Yue Ning Lam; Jing Xian Teo; Atsushi Kaneda; Kevin P White; Weng Khong Lim; Steven G Rozen; Bin Tean Teh; Shang Li; Anders J Skanderup; Patrick Tan
Journal:  Gut       Date:  2019-09-21       Impact factor: 23.059

8.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

9.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

10.  A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.

Authors:  Stefan Gröschel; Mathijs A Sanders; Remco Hoogenboezem; Elzo de Wit; Britta A M Bouwman; Claudia Erpelinck; Vincent H J van der Velden; Marije Havermans; Roberto Avellino; Kirsten van Lom; Elwin J Rombouts; Mark van Duin; Konstanze Döhner; H Berna Beverloo; James E Bradner; Hartmut Döhner; Bob Löwenberg; Peter J M Valk; Eric M J Bindels; Wouter de Laat; Ruud Delwel
Journal:  Cell       Date:  2014-04-03       Impact factor: 41.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.